CLOSED-LOOP CONTROL OF GLUCOSE ACCORDING TO A PREDICTED BLOOD GLUCOSE TRAJECTORY

Patent №

US 9,750,878

Granted

2017-09-05

Filed 2013

Owner

MEDTRONIC MINIMED, INC.

Lab

AI components

1

kr

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

14103522

Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, and affects a future command to an infusion pump to affect a cost value according to the cost expression. Another methodology defines a target blood glucose concentration level for the patient, observes a current blood glucose concentration for the patient based on signals received from a blood-glucose sensor, and predicts a duration of time for the patient's blood glucose concentration to reach the target blood glucose concentration level based on the observed current blood glucose concentration.

Knowledge representationA61M 5/1723A61B 5/14532A61B 5/4839A61B 5/7275G16H 20/17A61B 5/6849A61M 5/14244A61M 2205/33+2 more

AI classification

Knowledge representation0.80
Planning0.41
Evolutionary computation0.23
Machine learning0.05
Natural language0.01
AI hardware0.00
Vision0.00
Speech0.00

Ownership

MEDTRONIC MINIMED, INC.

assignment · 317620607

Assignors

ROY, ANIRBAN, KEENAN, DESMOND BARRY, KOVELMAN, PAUL H.

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC